Recurrent and nonrandom DNA copy number and chromosome alterations in Myc transgenic mouse model for hepatocellular carcinogenesis: implications for human disease

Cancer Genetics and Cytogenetics

Volumn 191, Issue 1, 2009, Pages 17-26

  Zimonjic, Drazen B ^a   Ullmannova Benson, Veronika ^a   Factor, Valentina M ^a   Thorgeirsson, Snorri S ^a   Popescu, Nicholas C ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; MYC PROTEIN;

ANIMAL CELL; ARTICLE; AUTOSOME; CHROMOSOME ABERRATION; CHROMOSOME BREAKAGE; CHROMOSOME LOSS; CHROMOSOME REARRANGEMENT; CONTROLLED STUDY; DNA DETERMINATION; GENE DELETION; KARYOTYPING; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MOUSE; NONHUMAN; ONCOGENE MYC; PRIORITY JOURNAL; TRANSGENIC MOUSE;

MUS; MUS MUSCULUS;

ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CHROMOSOME ABERRATIONS; CHROMOSOMES, MAMMALIAN; COMPARATIVE GENOMIC HYBRIDIZATION; DISEASE MODELS, ANIMAL; DNA, NEOPLASM; GENE DOSAGE; GENE REARRANGEMENT; HUMANS; INJECTIONS, SUBCUTANEOUS; LIVER NEOPLASMS; MICE; MICE, TRANSGENIC; PROTO-ONCOGENE PROTEINS C-MYC; SPECTRAL KARYOTYPING;

EID: 64649092340     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2008.12.014     Document Type: Article

References (48)

1. Sandberg A.A. The chromosomes in human cancer and leukemia. 2nd ed. (1990), Elsevier Science Publishing, New York
2. Mitelman F., Mertens F., and Johansson B. A breakpoint map of recurrent chromosomal rearrangements in human neoplasia. Nat Genet (1997) 15 Spec No:417-74
3. Hanahan D., and Weinberg R.A. The hallmarks of cancer. Cell 100 (2000) 57-70
4. Thorgeirsson S.S., and Grisham J.W. Molecular pathogenesis of human hepatocellular carcinoma. Nat Genet 31 (2002) 339-346
5. Murakami H., Sanderson N.D., Nagy P., Marino P.A., Merlino G., and Thorgeirsson S.S. Transgenic mouse model for synergistic effects of nuclear oncogenes and growth factors in tumorigenesis: interaction of c-myc and transforming growth factor α in hepatic oncogenesis. Cancer Res 53 (1993) 1719-1723
6. Etiemble J., Degott C., Renard C.A., Fourel G., Shamoon B., Vitvitski-Trépo L., Hsu T.Y., Tiollais P., Babinet C., and Buendia M.A. Liver-specific expression and high oncogenic efficiency of a c-myc transgene activated by woodchuck hepatitis virus insertion. Oncogene 9 (1994) 727-737
7. Santoni-Rugiu E., Nagy P., Jensen M.R., Factor V.M., and Thorgeirsson S.S. Evolution of neoplastic development in the liver of transgenic mice co-expressing c-myc and transforming growth factor-α. Am J Pathol 149 (1996) 407-428
8. Sargent L.M., Sanderson N.D., and Thorgeirsson S.S. Ploidy and karyotypic alterations associated with early events in the development of hepatocarcinogenesis in transgenic mice harboring c-myc and transforming growth factor α transgenes. Cancer Res 56 (1996) 2137-2142
9. Zimonjic D.B., Zhang H., Shan Z., Factor V.M., Trent J., Thorgeirsson S.S., and Popescu N.C. DNA amplification associated with double minutes originating from chromosome 19 in mouse hepatocellular carcinoma. Cytogenet Cell Genet 93 (2001) 114-116
10. Sargent L.M., Zhou X., Keck C.L., Sanderson N.D., Zimonjic D.B., Popescu N.C., and Thorgeirsson S.S. Nonrandom cytogenetic alterations in hepatocellular carcinoma from transgenic mice overexpressing c-Myc and transforming growth factor α in the liver. Am J Pathol 154 (1999) 1047-1055
11. Wu Y., Renard C.A., Apiou F., Huerre M., Tiollais P., Dutrillaux B., and Buendia A. Recurrent allelic deletions at mouse chromosome 4 and 14 in Myc-induced liver tumors. Oncogene 21 (2002) 1518-1526
12. Zimonjic D.B., Pollock J.L., Westervelt P., Popescu N.C., and Ley T.J. Acquired, nonrandom chromosomal abnormalities associated with the development of acute promyelocytic leukemia in transgenic mice. Proc Natl Acad Sci U S A 97 (2000) 13306-13311
13. CSGNM. Committee on Standardized Genetic Nomenclature for Mice. Chairperson Davisson MT. Rules for nomenclature of chromosome anomalies. In: Lyon M.F., Rastan S., and Brown S.D.M. (Eds). Genetic Variants and Strains of the Laboratory Mouse (1996), Oxford University Press, Oxford UK 1443-1445
14. Danielsen H.E., Brøgger A., and Reith A. Specific gain of chromosome 19 in preneoplastic liver cells after diethylnitrosamine treatment. Carcinogenesis 12 (1991) 1777-1780
15. Ogawa K., Osanai M., Obata M., Ishizaki K., and Kamiya K. Gain of chromosomes 15 and 19 is frequent in both mouse hepatocellular carcinoma cell lines and primary tumors, but loss of chromosome 4 and 12 is detected only in the cell lines. Carcinogenesis 20 (1999) 2083-2088
16. Zimonjic D.B., Keck C.L., Thorgeirsson S.S., and Popescu N.C. Novel recurrent genetic imbalances in human hepatocellular carcinoma cell lines identified by comparative genomic hybridization. Hepatology 29 (1999) 1208-1214
17. Keck C.L., Zimonjic D.B., Yuan B.Z., Thorgeirsson S.S., and Popescu N.C. Nonrandom breakpoints of unbalanced chromosome translocations in human hepatocellular carcinoma cell lines. Cancer Genet Cytogenet 111 (1999) 37-44
18. Popescu N.C., and Zimonjic D.B. Chromosome-mediated alterations of the MYC gene in human cancer. J Cell Mol Med 6 (2002) 151-159
19. Guffei A., Lichtensztejn Z., Gonçalves dos Santos Silva A., Louis S.F., Caporali A., and Mai S. c-Myc-dependent formation of Robertsonian translocation chromosomes in mouse cells. Neoplasia 9 (2007) 578-588
20. Xue W., Krasnitz A., Lucito R., Sordella R., VanAelst L., Cordon-Cardo C., Singer S., Kuehnel F., Wigler M., Powers S., Zender L., and Lowe S.W. DLC1 is a chromosome 8p tumor suppressor whose loss promotes hepatocellular carcinoma. Genes Dev 22 (2008) 1439-1444
21. Manenti G., Binelli G., Gariboldi M., Canzian F., De Gregoria L., Falvella F.S., Dragani T.A., and Pierotti M.A. Multiple loci affect predisposition to hepatocarcinogenesis in mice. Genomics 23 (1994) 118-124
22. Alitalo K., and Schwab M. Oncogene amplification in tumor cells. Adv Cancer Res 47 (1986) 235-281
23. Schimke R.T. Gene amplification in cultured cells. J Biol Chem 263 (1988) 5989-5992
24. Edelhoff S., Ayer D.E., Zervos A.S., Steingrímsson E., Jenkins N.A., Copeland N.G., Eisenman R.N., Brent R., and Disteche C.M. Mapping of two genes encoding members of a distinct subfamily of MAX interacting proteins: MAD to human chromosome 2 and mouse chromosome 6, and MXI1 to human chromosome 10 and mouse chromosome 19. Oncogene 9 (1994) 665-668
25. Sugiyama A., Noguchi K., Kitanaka C., Katou N., Tashiro F., Ono T., Yoshida M.C., and Kuchino Y. Molecular cloning and chromosomal mapping of mouse intronless. Myc gene acting as a potent apoptosis inducer. Gene 226 (1999) 273-283
26. Lemmer E.R., Welch J.L., Tsai T., Keck-Waggoner C.L., Huh C., Zimonjic D.B., Popescu N.C., and Thorgeirsson S.S. Genomic structure and chromosome location of the mouse RelA p65 gene (Rela). Cytogenet Cell Genet 89 (2000) 129-132
27. Shan Z.H., and Popescu N.C. Reassignment of Mycs gene to mouse chromosome XA1.2-2 by radiation hybrid mapping and fluorescence in situ hybridization. Cytogenet Genome Res 97 (2002) 152-153 [140G1-2]
28. Hodgson J.G., Malek T., Bornstein S., Hariono S., Ginzinger D.G., Muller W.J., and Gray J.W. Copy number aberrations in mouse breast tumors reveal loci and genes important in tumorigenic receptor tyrosine kinase signaling. Cancer Res 65 (2005) 9695-9704
29. Miyasaka K., Ohtake K., Nomura K., Kanda H., Kominami R., Miyashita N., and Kitagawa T. Frequent loss of heterozygosity on chromosome 4 in diethylnitrosamine-induced C3H/MSM mouse hepatocellular carcinomas in culture. Mol Carcinog 13 (1995) 37-43
30. Bièche I., Champème M.H., Matifas F., Cropp C.S., Callahan R., and Lidereau R. Two distinct regions involved in 1p deletion in human primary breast cancer. Cancer Res 53 (1993) 1990-1994
31. Jonasson J., Povey S., and Harris H. The analysis of malignancy by cell fusion: VII. Cytogenetic analysis of hybrids between malignant and diploid cells and of tumours derived from them. J Cell Sci 24 (1977) 217-254
32. Drinkwater N.R. Genetic control of hepatocarcinogenesis in C3H mice. Drug Metab Rev 26 (1994) 201-208
33. Grisham J.W. Interspecies comparison of liver carcinogenesis implications for cancer risk assessment. Carcinogenesis 18 (1996) 59-81
34. Davis L.M., Caspary W.J., Sakallah S.A., Maronpot R., Wiseman R., Barrett J.C., Elliott R., and Hozier J.C. Loss of heterozygosity in spontaneous and chemically induced tumors of the B6C3F1 mouse. Carcinogenesis 15 (1994) 1637-1645
35. Huebner K., and Croce C.M. FRA3B and other common fragile sites: the weakest links. Nat Rev Cancer 1 (2001) 214-221
36. Schlott T., Ahrens K., Ruschenburg I., Reimer S., Hartmann H., and Droese M. Different gene expression of MDM2 GAGE-1, -2 and FHIT in hepatocellular carcinoma and focal nodular hyperplasia. Br J Cancer 80 (1999) 73-78
37. Yuan B.Z., Keck-Waggoner C., Zimonjic D.B., Thorgeirsson S.S., and Popescu N.C. Alterations of the FHIT gene in human hepatocellular carcinoma. Cancer Res 60 (2000) 1049-1053
38. Tsujiuchi T., Sasaki Y., Kubozoe T., Tsutsumi M., Konishi Y., and Nakae D. Alterations of the Fhit gene in hepatocellular carcinomas induced by N nitrosodiethylamine in rats. Mol Carcinog 34 (2002) 19-24
39. Bonyadi M., Cui W., Nagase H., and Akhurst R.J. The TGF β type II receptor, Tgfbr2, maps to distal mouse chromosome 9. Genomics 33 (1996) 328-329
40. Mathew S., Murty V.V., Cheifetz S., George D., Massague J., and Chaganti R.R. Transforming growth factor receptor gene TGFBR2 maps to human chromosome band 3p22. Genomics 20 (1994) 114-115
41. Sue S.R., Chari R.S., Kong F.M., Mills J.J., Fine R.L., Jirtle R.L., and Meyers W.C. Transforming growth factor-β receptors and mannose 6-phosphate/insulin-like growth factor-II receptor expression in human hepatocellular carcinoma. Ann Surg 222 (1995) 171-178
42. Santoni-Rugiu E., Jensen M.R., and Thorgeirsson S.S. Disruption of the pRb/E2F pathway and inhibition of apoptosis are major oncogenic events in liver constitutively expressing c-myc and transforming growth factor α. Cancer Res 58 (1998) 123-134
43. Imreh S., Klein G., and Zabarovsky E.R. Search for unknown tumor-antagonizing genes. Genes Chromosomes Cancer 38 (2003) 307-321
44. Zhou X., Popescu N.C., Klein G., and Imreh S. The interferon-α responsive gene TMEM7 suppresses cell proliferation and is downregulated in human hepatocellular carcinoma. Cancer Genet Cytogenet 177 (2007) 6-15
45. Pathak S., Dave B.J., and Gadhia P.K. Mouse chromosome 14 is altered in different metastatic murine neoplasias. Cancer Genet Cytogenet 83 (1995) 172-173
46. Birnbaum D., Adélaïde J., Popovici C., Charafe-Jauffret E., Mozziconacci M.J., and Chaffanet M. Chromosome arm 8p and cancer: a fragile hypothesis. Lancet Oncol 4 (2003) 639-642
47. Popescu N.C. Fragile sites and cancer genes on the short arm of chromosome 8. Lancet Oncol 5 (2004) 77
48. Durkin M.E., Keck-Waggoner C.L., Popescu N.C., and Thorgeirsson S.S. Integration of a c-myc transgene results in disruption of the mouse Gtf2ird1 gene, the homologue of the human GTF2IRD1 gene hemizygously deleted in Williams-Beuren syndrome. Genomics 73 (2001) 20-27